General Information of Drug Off-Target (DOT) (ID: OTKQKNTC)

DOT Name Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2)
Synonyms HESB-like domain-containing protein 1
Gene Name ISCA2
Related Disease
Mitochondrial disease ( )
Multiple mitochondrial dysfunctions syndrome 3 ( )
Fatal multiple mitochondrial dysfunctions syndrome ( )
Multiple mitochondrial dysfunctions syndrome 4 ( )
Leukodystrophy ( )
UniProt ID
ISCA2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF01521
Sequence
MAAAWGSSLTAATQRAVTPWPRGRLLTASLGPQARREASSSSPEAGEGQIRLTDSCVQRL
LEITEGSEFLRLQVEGGGCSGFQYKFSLDTVINPDDRVFEQGGARVVVDSDSLAFVKGAQ
VDFSQELIRSSFQVLNNPQAQQGCSCGSSFSIKL
Function Involved in the maturation of mitochondrial 4Fe-4S proteins functioning late in the iron-sulfur cluster assembly pathway. May be involved in the binding of an intermediate of Fe/S cluster assembly.
Reactome Pathway
Mitochondrial iron-sulfur cluster biogenesis (R-HSA-1362409 )

Molecular Interaction Atlas (MIA) of This DOT

5 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Mitochondrial disease DISKAHA3 Definitive Autosomal recessive [1]
Multiple mitochondrial dysfunctions syndrome 3 DISTIUPO Definitive Genetic Variation [2]
Fatal multiple mitochondrial dysfunctions syndrome DISYBW5F Strong Genetic Variation [3]
Multiple mitochondrial dysfunctions syndrome 4 DIS42DWP Strong Autosomal recessive [4]
Leukodystrophy DISVY1TT Limited Biomarker [5]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [6]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [7]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [8]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [9]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [10]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [11]
Testosterone DM7HUNW Approved Testosterone increases the expression of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [12]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Iron-sulfur cluster assembly 2 homolog, mitochondrial (ISCA2). [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
2 ISCA1 mutation in a patient with infantile-onset leukodystrophy causes defects in mitochondrial [4Fe-4S] proteins.Hum Mol Genet. 2018 Aug 1;27(15):2739-2754. doi: 10.1093/hmg/ddy183.
3 Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. Cell Rep. 2015 Jan 13;10(2):148-61. doi: 10.1016/j.celrep.2014.12.015. Epub 2014 Dec 31.
4 The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
5 Further delineation of the phenotypic spectrum ofISCA2 defect: A report of ten new cases.Eur J Paediatr Neurol. 2018 Jan;22(1):46-55. doi: 10.1016/j.ejpn.2017.10.003. Epub 2017 Oct 16.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
8 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
9 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
10 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
11 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
12 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
13 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.